Vicore Pharma: Video interview with CEO Per Jansson
Redeye Research Interview
2017/04/10
CEO Per Jansson explains the outcome of two recent safety studies, the choice of making a private placement and Vicore Pharma’s development plans going forward.
You need to be a Redeye member to access this content
Become a member to:
Access all our extensive research on 100+ Nordic Tech and Life Science companies
Make smarter investment decisions with the guidance of our experienced analysts
Receive exciting offers to participate in IPO’s and other transactions
By clicking "Sign up" you indicate that you read and agree to our Terms & Conditions